Table 1.
Baseline demographic characteristics* of people using varenicline and bupropion to help with tobacco use cessation in nationwide registry based cohort study in Denmark, with follow-up from January 2007 to December 2010. Figures are numbers (percentage) of participants unless stated otherwise
| Variable | Varenicline (n=17 926) | Bupropion (n=17 926) |
|---|---|---|
| Men | 8639 (48) | 8674 (48) |
| Mean (SD) age (years) | 48.4 (12.8) | 48.5 (12.8) |
| Calendar year: | ||
| 2007 | 4089 (23) | 6818 (38) |
| 2008 | 4512 (25) | 4154 (23) |
| 2009 | 4322 (24) | 3524 (20) |
| 2010 | 5003 (28) | 3430 (19) |
| Region of residence: | ||
| Greater Copenhagen | 4836 (27) | 4911 (27) |
| Zealand | 3081 (17) | 3066 (17) |
| Southern Denmark | 4851 (27) | 4795 (27) |
| Central Denmark | 3474 (19) | 3468 (19) |
| North Denmark | 1684 (9) | 1686 (9) |
| Degree of urbanisation: | ||
| Population density (inhabitants/km2): | ||
| ≤49 | 1056 (6) | 1022 (6) |
| 50-99 | 5105 (28) | 5024 (28) |
| 100-199 | 4462 (25) | 4493 (25) |
| ≥200 | 1764 (10) | 1759 (10) |
| Copenhagen suburbs | 3919 (22) | 3984 (22) |
| Copenhagen | 1620 (9) | 1644 (9) |
| Country of birth: | ||
| Denmark | 16 842 (94) | 16 847 (94) |
| Europe | 488 (3) | 462 (3) |
| Rest of world | 596 (3) | 617 (3) |
*Matched for propensity score.